Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2022
Addex and Indivior extend GABAB PAM collaboration
Addex Therapeutics reported that its strategic collaboration with Indivior on GABAB PAM had been extended with an additional $4 million in funding.
2021
AELIS FARMA and INDIVIOR announce collaboration and option-license agreement
AELIS FARMA announced a strategic collaboration and option-license agreement with INDIVIOR for AEF0117, a drug candidate for cannabis-related disorders. INDIVIOR was granted an option for an exclusive worldwide license; AELIS will conduct development during the option period.
2019
Indivior launches Keep Moving Towards Recovery campaign
Indivior announced the launch of its Keep Moving Towards Recovery direct-to-consumer advertising campaign to raise awareness of treatment with SUBLOCADE and encourage people affected by opioid use disorder and those who care about them to seek help from health care professionals.